Variety of eligible individuals: CDEC mentioned the uncertainty in the number of patients with reasonably critical to critical hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific gurus consulted by CADTH indicated that some clients who're classified as having delicate or reasonable illness may have a extreme bleeding phenotype, which https://hemgenix72593.blog5star.com/36323948/hemgenix-options